Bellingham, MA, United States of America

John Moore Maclennan


Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2000-2006

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of John Moore Maclennan

Introduction

John Moore Maclennan is a notable inventor based in Bellingham, MA (US). He has made significant contributions to the field of biotechnology, particularly in the purification of tissue plasminogen activator (tPA). With a total of 4 patents to his name, Maclennan's work has had a substantial impact on medical research and applications.

Latest Patents

One of Maclennan's latest patents focuses on the purification of tissue plasminogen activator (tPA). This method discloses a way to obtain affinity ligands for isolating tPA. The ligands bind to tPA with high specificity at pH 7 and release tPA at pH 5 or lower. Additionally, the patent outlines methods for isolating additional ligands with desirable binding and release characteristics. This innovation allows for the development of tailored ligands to address specific purification challenges presented by various feed streams containing tPA.

Career Highlights

Throughout his career, John Moore Maclennan has worked with several companies, including Dyax Corporation. His expertise in biotechnology and patent development has positioned him as a key figure in his field. His contributions have not only advanced scientific understanding but have also paved the way for new therapeutic applications.

Collaborations

Maclennan has collaborated with notable individuals in the industry, including Robert Charles Ladner and Thomas Cushman Ransohoff. These partnerships have further enhanced his research and innovation efforts.

Conclusion

John Moore Maclennan's work in the purification of tissue plasminogen activator exemplifies the importance of innovation in biotechnology. His patents and collaborations reflect a commitment to advancing medical science and improving therapeutic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…